These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11334654)

  • 1. Tissue factor/tissue factor pathway inhibitor system and long-term prognosis after acute myocardial infarction.
    Roldán V; Marín F; Fernández P; Luján J; Martínez JG; Pineda J; Marco P; Sogorb F
    Int J Cardiol; 2001 Apr; 78(2):115-9. PubMed ID: 11334654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Blankenberg S; Alessi MC; Bickel C; Rupprecht HJ; Schnabel R; Lubos E; Münzel T; Peetz D; Nicaud V; Juhan-Vague I; Tiret L;
    J Thromb Haemost; 2007 Mar; 5(3):475-82. PubMed ID: 17204132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina.
    Soejima H; Ogawa H; Yasue H; Kaikita K; Nishiyama K; Misumi K; Takazoe K; Miyao Y; Yoshimura M; Kugiyama K; Nakamura S; Tsuji I; Kumeda K
    Circulation; 1999 Jun; 99(22):2908-13. PubMed ID: 10359735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvastatin and tissue factor pathway inhibitor in type IIA and IIB hyperlipidemia and in acute myocardial infarction.
    Lorena M; Perolini S; Casazza F; Milani M; Cimminiello C
    Thromb Res; 1997 Aug; 87(4):397-403. PubMed ID: 9271817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects : impact of the V264M substitution on plasma levels of TFPI.
    Moatti D; Seknadji P; Galand C; Poirier O; Fumeron F; Desprez S; Garbarz M; Dhermy D; Arveiler D; Evans A; Luc G; Ruidavets JB; Ollivier V; Hakim J; Aumont MC; de Prost D
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):862-9. PubMed ID: 10195910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study.
    Morange PE; Simon C; Alessi MC; Luc G; Arveiler D; Ferrieres J; Amouyel P; Evans A; Ducimetiere P; Juhan-Vague I;
    Circulation; 2004 Mar; 109(11):1343-8. PubMed ID: 15023872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma tissue factor and tissue factor pathway inhibitor levels in acute myocardial infarction patients with no-reflow during percutaneous coronary intervention].
    Xu P; Qi XY; Li CH; Zhang JH; Liu DM; Liu J; Wang WL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1013-5. PubMed ID: 19102916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes.
    Golino P; Ravera A; Ragni M; Cirillo P; Piro O; Chiariello M
    Circulation; 2003 Dec; 108(23):2864-9. PubMed ID: 14656922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age.
    Moor E; Hamsten A; Karpe F; Båvenholm P; Blombäck M; Silveira A
    Thromb Haemost; 1994 Jun; 71(6):707-12. PubMed ID: 7974336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
    Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation activation in young survivors of myocardial infarction (MI)--a population-based case-control study.
    Brodin E; Børvik T; Sandset PM; Bønaa KH; Nordøy A; Hansen JB
    Thromb Haemost; 2004 Jul; 92(1):178-84. PubMed ID: 15213859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
    Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolysis of tissue factor pathway inhibitor-1 by thrombolysis in acute myocardial infarction.
    Ott I; Malcouvier V; Schömig A; Neumann FJ
    Circulation; 2002 Jan; 105(3):279-81. PubMed ID: 11804978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
    Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
    Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
    Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower tissue factor inhibition in patients with ST segment elevation than in patients with non ST elevation acute myocardial infarction.
    Figueras J; Monasterio J; Lidón RM; Sambola A; Garcia-Dorado D
    Thromb Res; 2012 Sep; 130(3):458-62. PubMed ID: 22424853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].
    Saito M; Morishita E; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Matsuda T
    Rinsho Ketsueki; 1996 Sep; 37(9):794-8. PubMed ID: 8914465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndrome.
    Malý M; Vojácek J; Hrabos V; Kvasnicka J; Salaj P; Durdil V
    Physiol Res; 2003; 52(6):719-28. PubMed ID: 14640893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
    Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
    Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.